Screening and production of arylsulfatases for target therapy with etoposide 4'-sulfate, an antitumor prodrug

Biosci Biotechnol Biochem. 1995 Jun;59(6):1057-61. doi: 10.1271/bbb.59.1057.

Abstract

Two arylsulfatase-producing streptomycetes that desulfated etoposide 4'-sulfate were isolated from soil samples. Taxonomical study identified one soil isolate as Streptomyces griseorubiginosus S980-14 (Es-1 arylsulfatase producer), while the other was considered new and tentatively designated Streptomyces sp. T109-3 (Es-2 arylsulfatase producer). Both strains produced extracellular arylsulfatase activities, provided that cultivation media were prepared with distilled water. Unlike the two known types of arylsulfatases, which had significant activity on p-nitrophenyl sulfate but none on etoposide 4'-sulfate, the crude streptomycete arylsulfatases efficiently desulfated etoposide 4'-sulfate and p-nitrophenyl sulfate, which supports the establishment of a new type of arylsulfatases.

MeSH terms

  • Antineoplastic Agents / metabolism
  • Antineoplastic Agents / pharmacology*
  • Arylsulfatases / biosynthesis*
  • Carbohydrate Sequence
  • Etoposide / analogs & derivatives*
  • Etoposide / metabolism
  • Etoposide / pharmacology
  • Fermentation
  • Microscopy, Electron, Scanning
  • Molecular Sequence Data
  • Prodrugs / metabolism
  • Prodrugs / pharmacology*
  • Streptomyces / classification
  • Streptomyces / enzymology*
  • Streptomyces / ultrastructure
  • Sulfuric Acid Esters / metabolism
  • Sulfuric Acid Esters / pharmacology*

Substances

  • Antineoplastic Agents
  • Prodrugs
  • Sulfuric Acid Esters
  • etoposide 4'-sulfate
  • Etoposide
  • Arylsulfatases